Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Liang Huang
CONTACT
Lead
Institute of Hematology & Blood Diseases Hospital, China
This is a single-arm, open-label, dose exploratory clinical study to evaluate the safety, efficacy, cellular pharmacokinetics, and pharmacodynamics of CT1194C cells in patients with B-NHL. It is planned to enroll 3-27 participants.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted